Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mind Medicine (MindMed) Inc. - Common Shares (NQ: MNMD )

9.890 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
32 33 Next >
MindMed Reports Full Year 2021 Financial Results, Announces Changes In Leadership
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) reported its financial results for the full year ended December 31, ... 
Via Benzinga
Earnings Scheduled For March 28, 2022
Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million. 
Via Benzinga
Psychedelic Compounds-Based Drug Stocks Down Slightly This Past Week
We're tracking 13 public companies (US and/or Canada) doing clinical-stage research into THC and/or psychedelics for treating mental illnesses. While a few were up this week, the overall trend... 
Via Talk Markets
Psychedelic Stock Gainers And Losers From March 25, 2022
GAINERS: Allied (OTC: 
Via Benzinga
Allied, Field Trip Health Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC: 
Via Benzinga
Five Companies Developing Second Generation Psychedelics For Mental Health
Along with the psychedelic renaissance came a new type of drug: second generation psychedelics. Developed from classic psychedelics ... 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 23, 2022
GAINERS: Compass Pathways (NASDAQ: 
Via Benzinga
Mindset Pharma, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ: 
Via Benzinga
Psyched: MindCure Shuts Down Operations, Novamind And MindMed Partner For Study
The psychedelics space was shaken up on the news thatMindCure Health (OTC: MCURF) was shutting down operations. 
Via Benzinga
Field Trip Health, Mindset Pharma Among Top Psychedelic Movers Of Today
GAINERS: Field Trip Health (NASDAQ: 
Via Benzinga
Psychedelic Compounds-Based Drug Stocks Index Bounces Back
Updating the stock performances of the 13 constituents in our Pure-Play Marijuana and Psychedelic Compounds-Based Drug Stocks Index: up last week but still down 32% YTD. 
Via Talk Markets
Field Trip Health, Allied Among Top Psychedelic Movers Of Today
GAINERS: Field Trip Health (NASDAQ: 
Via Benzinga
'Psychedelics Companies Are Onto Something Extraordinary,' Says Kevin O'Leary: Meet Our Keynote Speakers
Whether you're into finances or just a fan of Shark Tank, chances are you know who Kevin O’L... 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 16, 2022
GAINERS: Mindset Pharma (OTC: 
Via Benzinga
Novamind To Host MindMed Phase IIb Trial For LSD Based Drug For Anxiety Treatment
Novamind Inc. (OTCQB: NVMDF) (CSE:NM) (FSE:HN2) has been selected by Mind Medicine, Inc. (NASDAQ: MNMD)(NEO:MMED) to host ... 
Via Benzinga
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ: 
Via Benzinga
Wellbeing Digital, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC: 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 10, 2022
GAINERS: Revive Therapeutics (OTC: 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 9, 2022
GAINERS: ATAI Life Sciences (NASDAQ: 
Via Benzinga
Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council
DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the ... 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 7, 2022
GAINERS: GH Research (NASDAQ: 
Via Benzinga
NetworkNewsAudio – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Differentiates Itself in Psychedelics Space
Via Investor Brand Network
Psychedelic Stock Gainers And Losers From March 4, 2022
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 3, 2022
GAINERS: Seelos Therapeutics (NASDAQ: 
Via Benzinga
LSD And Magic Mushroom's Active Compound Appear To Have The Same Effects, New Study Finds
A new peer-reviewed study compared the effects of LSD and psilocybin, two substances currently standing as top molecules behind the recent psychede... 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 2, 2022
GAINERS: Mindset Pharma (OTC: 
Via Benzinga
Psychedelic Therapies Offer Hope For Mental Health
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.... 
Via Benzinga
Psychedelic Therapies Offer Hope for Mental Health
Via Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
Via Investor Brand Network
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS